We are live on ! Find out more
RAIN

Rain Oncology Inc. Common Stock
RAIN

Delisted

RAIN was delisted on the 25th of January, 2024.

Back to rankings

38 hedge funds and large institutions have $73.9M invested in Rain Oncology Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less capital invested

Capital invested by funds: $77.7M → $73.9M (-$3.81M)

5% less funds holding

Funds holding: 40 → 38 (-2)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

Holders
38
Holders Change
-2
Holders Change %
-5%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$5.56M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.13M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$765K
4
Citadel Advisors
Citadel Advisors
Florida
+$357K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$142K

Top Sellers

Rank Fund Capital Flow
1
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$158K
2
Bank of America
Bank of America
North Carolina
-$128K
3
Millennium Management
Millennium Management
New York
-$65.7K
4
First Trust Advisors
First Trust Advisors
Illinois
-$62K
5
Goldman Sachs
Goldman Sachs
New York
-$56K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$53K -$48.2K -7,683 -41%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$52K -$14.8K -2,362 -18%
LFM
28
Lumina Fund Management
New York
$29K – – –
TRCT
29
Tower Research Capital (TRC)
New York
$19K +$18.3K +2,917 +279%
SBL
30
Sargent Bickham Lagudis
Colorado
$11K +$14.6K +2,332 New
UBS Group
31
UBS Group
Switzerland
$8K +$10.7K +1,698 New
JP Morgan Chase
32
JP Morgan Chase
New York
$3K – – –
GRP
33
Global Retirement Partners
California
$2K – – –
Citigroup
34
Citigroup
New York
$1K -$1.35K -215 -49%
CUAMC
35
China Universal Asset Management Company
China
$1K +$1.1K +176 New
Thrivent Financial for Lutherans
36
Thrivent Financial for Lutherans
Minnesota
– -$158K -28,401 Closed
First Trust Advisors
37
First Trust Advisors
Illinois
– -$62K -11,223 Closed
Goldman Sachs
38
Goldman Sachs
New York
– -$56K -10,072 Closed
Wells Fargo
39
Wells Fargo
California
– -$6.17K -982 -94%
Northwestern Mutual Wealth Management
40
Northwestern Mutual Wealth Management
Wisconsin
– -$1K -200 Closed
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
– -$1K -131 Closed
EI
42
Ellevest Inc
New York
– -$220 -35 -78%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
– +$151 +24 New
1
2

RAIN Hedge Fund Activity: Q3 2022 in Review

38 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q3 2022, worth a combined $73.9M — down 4.9% from $77.7M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of RAIN and 5 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 8 added.

The largest buyer was Janus Henderson Group, adding an estimated $5.56M. The largest seller was Thrivent Financial for Lutherans, exiting entirely with an estimated $158K sold.

  • 38 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q3 2022, down from 40 in Q2 2022.
  • Funds reported $73.9M of Rain Oncology Inc. Common Stock stock for Q3 2022, down 4.9% quarter-over-quarter.
  • 5 funds opened new Rain Oncology Inc. Common Stock positions in Q3 2022 and 6 closed out, a net change of -1 holder.
  • The largest Rain Oncology Inc. Common Stock buyer in Q3 2022 was Janus Henderson Group, an estimated $5.56M added.
  • The largest Rain Oncology Inc. Common Stock seller in Q3 2022 was Thrivent Financial for Lutherans, an estimated $158K sold.

Based on aggregated 13F filings for Q3 2022.